Who invested in Zenas BioPharma?
Zenas BioPharma's investors include New Enterprise Associates, Norwest Venture Partners, Wellington Management, Vivo Capital and SR One, and 11 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$420Mraised across 3 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
Reported by Tellus BioVenturesSEC filing: $200M sold, first sale May 2024
From Zenas BioPharma's own website and the SEC filings it signed: 1 founder, 11 on the team.
On the board, as filediHongbo O. LuJohn Jacob OrloffTim Jacob XiaoTomas O. Kiselak
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Zenas BioPharma's investors include New Enterprise Associates, Norwest Venture Partners, Wellington Management, Vivo Capital and SR One, and 11 more on record.
Zenas BioPharma has raised $420M across 3 rounds since 2024.
Zenas BioPharma's most recent round was an Undisclosed round of $100M in Mar 2026.
Zenas BioPharma's largest round on record is $200M (Series C), in May 2024, led by New Enterprise Associates.
Zenas BioPharma's first round on record, in May 2024, was backed by New Enterprise Associates, Norwest Venture Partners and SR One and 12 others.
Zenas BioPharma's latest named round is an Undisclosed round, in Mar 2026.
Zenas BioPharma is based in the United States.
New Enterprise Associates led the Series C in 2024.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.